Medicine & Life Sciences
Taiwan
100%
Thymoma
95%
Protein-Tyrosine Kinases
72%
Non-Small Cell Lung Carcinoma
70%
Adenocarcinoma of Lung
63%
ErbB Receptors
56%
benzanthrone
41%
Atrial Fibrillation
35%
Epiregulin
33%
Survival
29%
Argon Plasma Coagulation
29%
Weaning
29%
Malignant Pleural Effusion
27%
Elderly
26%
Anaplastic Lymphoma Kinase
26%
Drug Therapy
26%
Neoplasms
25%
Hospices
24%
Salvage Therapy
23%
Recurrence
22%
Herbal Medicine
22%
Progression-Free Survival
21%
Gastrointestinal Diseases
21%
Independent Living
20%
Health Behavior
20%
Paclitaxel
20%
Ambulatory Care
19%
High-Throughput Nucleotide Sequencing
18%
Mutation
18%
Intensive Care Units
18%
Teaching Hospitals
18%
Respiration
18%
Metabolic Syndrome
18%
Multicenter Studies
17%
Therapeutics
14%
Meta-Analysis
14%
Systematic Reviews
14%
Medicine
14%
Mechanical Ventilators
14%
Epithelial Cells
14%
Ligands
13%
Macrophages
13%
Research Personnel
13%
Exercise
13%
Cohort Studies
13%
Lung Neoplasms
13%
Lung
10%
Odds Ratio
10%
7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile
10%
ceritinib
9%
Agriculture & Biology
thymoma
63%
carcinoma
62%
Taiwan
58%
adjuvants
26%
lung neoplasms
25%
paclitaxel
24%
neoplasms
22%
therapeutics
21%
medicine
17%
researchers
16%
World Health Organization
10%
rural areas
10%
urban areas
10%
resection
9%
surgery
9%
drug therapy
6%
immunotherapy
6%
cells
6%
thoracoscopy
5%
health insurance
5%
mutation
5%